Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Calcilytic compounds presented as a new therapy for bone and mineral diseases

March 13, 2002

OrthoLogic's IND approved for phase I/II trial of Chrysalin in spinal fusion

March 13, 2002

Biovitrum initiates phase I trials of BVT-3498

March 13, 2002

Merck & Co. scientists prepare new series of PPARgamma agonists

March 12, 2002

Novel glucokinase activators in the pipeline at Roche

March 12, 2002

Zentaris patents compounds useful for treating acromegaly

March 12, 2002

Scientists at GlaxoSmithKline design peptides binding to G-CSF receptor

March 11, 2002

Compounds that inhibit cholesterol biosynthesis and their uses claimed by Boehringer Ingelheim

March 8, 2002

Actonel found to be equieffective in weekly or daily doses in postmenopausal women

March 8, 2002

Uncoupling protein 3 polypeptides for the treatment of obesity and diabetes

March 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...